• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国喀什非结核分枝杆菌感染的分子特征及药敏谱分析

Molecular Characterization and Antibiograms of Nontuberculous Mycobacterium Infections in Kashgar, China.

作者信息

Wang Yiting, Zheng Huiwen, Wang Xijiang, Wang Xinqi, Liu Nianqiang, Wang Le, Liu Zhenjiang, Meng Xiangli, Abullimiti Maiweilanjiang, Aihemuti Maimaitiaili, Huang Fang, Huang Fei, Ou Xichao, Wang Senlu, Zhao Yanlin

机构信息

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.

Institute for Immunization and Prevention, Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control, Beijing 100013, China; Beijing Research Center for Respiratory Infectious Diseases, Beijing 100013, China; School of Public Health, Capital Medical University, Beijing, 100017, China.

出版信息

Curr Microbiol. 2025 Jul 11;82(9):376. doi: 10.1007/s00284-025-04357-0.

DOI:10.1007/s00284-025-04357-0
PMID:40643789
Abstract

To investigate the prevalent characteristic of nontuberculous mycobacteria (NTM) isolates in Kashgar. A total of 52 NTM culture-positive isolates were collected in 2020 from Kashgar, China. All strains were confirmed to be NTM species by whole genome sequencing (WGS). Drug susceptibility testing was performed using Sensititre SLOMYCO plates. Of the 52 NTM isolates, 88.46% (46/52) were rapidly growing mycobacteria (RGM). The predominant NTM species were Mycolicibacterium. sp (23.07%, 12/52) and M. elephantis (15.38%, 8/52), followed by Mycobacteroides chelonae (9.61%, 5/52). At least, two suspected new species were identified. Two core virulence genes were identified in more than 95% of the isolates. Antimicrobial susceptibility testing revealed high resistance among RGM isolates to imipenem (73.91%), while remained sensitive to amikacin and ciprofloxacin. All slowly growing mycobacteria isolates exhibited the highest resistance rate against doxycycline (83.3%, 5/6), but most strains were sensitive to clarithromycin, rifabutin, amikacin, ciprofloxacin, moxifloxacin, rifampin, and trimethoprim-sulfamethoxazole. The prevalence of NTM isolates in Kashgar presents a very specific features and some rarely reported species constitute big proportions. Amikacin and moxifloxacin may represent effective therapeutic options for NTM infections in Kashgar.

摘要

为调查喀什地区非结核分枝杆菌(NTM)分离株的流行特征。2020年从中国喀什共收集了52株NTM培养阳性分离株。所有菌株均通过全基因组测序(WGS)确认为NTM菌种。使用Sensititre SLOMYCO平板进行药敏试验。在52株NTM分离株中,88.46%(46/52)为快速生长分枝杆菌(RGM)。主要的NTM菌种为Mycolicibacterium. sp(23.07%,12/52)和象分枝杆菌(15.38%,8/52),其次是龟分枝杆菌(9.61%,5/52)。至少鉴定出两个疑似新菌种。在超过95%的分离株中鉴定出两个核心毒力基因。药敏试验显示,RGM分离株对亚胺培南的耐药率较高(73.91%),而对阿米卡星和环丙沙星仍敏感。所有缓慢生长分枝杆菌分离株对多西环素的耐药率最高(83.3%,5/6),但大多数菌株对克拉霉素、利福布汀、阿米卡星、环丙沙星、莫西沙星、利福平以及复方新诺明敏感。喀什地区NTM分离株的流行呈现出非常特殊的特征,一些罕见报道的菌种占比很大。阿米卡星和莫西沙星可能是喀什地区NTM感染的有效治疗选择。

相似文献

1
Molecular Characterization and Antibiograms of Nontuberculous Mycobacterium Infections in Kashgar, China.中国喀什非结核分枝杆菌感染的分子特征及药敏谱分析
Curr Microbiol. 2025 Jul 11;82(9):376. doi: 10.1007/s00284-025-04357-0.
2
Antimicrobial resistance of rapidly growing mycobacteria isolated from companion animals in Taiwan.台湾地区伴侣动物中分离出的快速生长分枝杆菌的抗菌耐药性。
Microbiol Spectr. 2025 Jul;13(7):e0307424. doi: 10.1128/spectrum.03074-24. Epub 2025 May 19.
3
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
4
Species diversity and clinical relevance of nontuberculous mycobacterium isolated from pulmonary and extrapulmonary samples in southeastern Turkey, 2014 to 2023: A retrospective cross-sectional study.2014年至2023年土耳其东南部肺和肺外样本中分离出的非结核分枝杆菌的物种多样性及临床相关性:一项回顾性横断面研究
Medicine (Baltimore). 2025 Jul 18;104(29):e43415. doi: 10.1097/MD.0000000000043415.
5
Negligible clinical impact of subsequent non-tuberculous mycobacteria isolation during MDR/RR-TB treatment: a 9-year retrospective cohort study from Wenzhou, China.耐多药/利福平耐药结核病治疗期间后续非结核分枝杆菌分离的临床影响可忽略不计:来自中国温州的一项9年回顾性队列研究
BMC Infect Dis. 2025 Jul 24;25(1):942. doi: 10.1186/s12879-025-11336-0.
6
Characterization of integrated prophages within diverse species of clinical nontuberculous mycobacteria.临床非结核分枝杆菌不同种属内整合噬菌体的特性研究。
Virol J. 2020 Aug 17;17(1):124. doi: 10.1186/s12985-020-01394-y.
7
The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysis.中国大陆非结核分枝杆菌感染的流行情况:系统评价和荟萃分析。
J Infect. 2016 Dec;73(6):558-567. doi: 10.1016/j.jinf.2016.08.020. Epub 2016 Oct 4.
8
Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.呼吸道常见临床相关非结核分枝杆菌分离株的抗菌药敏和最小抑菌浓度分布。
Ann Med. 2022 Dec;54(1):2500-2510. doi: 10.1080/07853890.2022.2121984.
9
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
10
Simultaneous detection and differentiation of and nontuberculous mycobacteria in smear-negative sputum by a multiplex PCR assay: a clinical feasibility study.通过多重聚合酶链反应检测方法同时检测和鉴别涂片阴性痰液中的结核分枝杆菌和非结核分枝杆菌:一项临床可行性研究。
Microbiol Spectr. 2025 Jul;13(7):e0231624. doi: 10.1128/spectrum.02316-24. Epub 2025 May 30.

本文引用的文献

1
Prevalence of nontuberculous mycobacteria and the emergence of rare species in Henan Province, China.中国河南省非结核分枝杆菌的流行情况及稀有菌种的出现。
Epidemiol Infect. 2024 May 6;152:e92. doi: 10.1017/S095026882400061X.
2
Mycobacterium chelonae soft-tissue infection in an immunocompetent child.免疫功能正常儿童的龟分枝杆菌软组织感染
J Paediatr Child Health. 2023 Feb;59(2):401-403. doi: 10.1111/jpc.16310. Epub 2022 Dec 29.
3
is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes.
是一种新兴的人类肺部疾病病原体:临床特征、抗菌药物敏感性检测和结果。
Emerg Microbes Infect. 2022 Dec;11(1):1973-1981. doi: 10.1080/22221751.2022.2103453.
4
Distribution and identification of Mycobacterium tuberculosis lineage in Kashgar prefecture.喀什地区结核分枝杆菌谱系的分布与鉴定。
BMC Infect Dis. 2022 Mar 30;22(1):312. doi: 10.1186/s12879-022-07307-4.
5
The Epidemiological Characteristics of Pulmonary Tuberculosis - Kashgar Prefecture, Xinjiang Uygur Autonomous Region, China, 2011-2020.2011 - 2020年中国新疆维吾尔自治区喀什地区肺结核的流行病学特征
China CDC Wkly. 2021 Jun 25;3(26):557-561. doi: 10.46234/ccdcw2021.144.
6
Lymphocutaneous spread of in an immunocompetent individual: A case report.
SAGE Open Med Case Rep. 2021 Jul 28;9:2050313X211034913. doi: 10.1177/2050313X211034913. eCollection 2021.
7
Investigation of two cases of Mycobacterium chelonae infection in haemato-oncology patients using whole-genome sequencing and a potential link to the hospital water supply.采用全基因组测序调查两例血液肿瘤患者感染龟分枝杆菌的病例,并探讨其与医院供水之间的潜在关联。
J Hosp Infect. 2021 Aug;114:111-116. doi: 10.1016/j.jhin.2021.04.028. Epub 2021 May 1.
8
Predictive study of tuberculosis incidence by time series method and Elman neural network in Kashgar, China.中国喀什基于时间序列法和 Elman 神经网络的结核病发病率预测研究。
BMJ Open. 2021 Jan 21;11(1):e041040. doi: 10.1136/bmjopen-2020-041040.
9
Small vessel vasculitis secondary to Mycobacterium chelonae.龟分枝杆菌继发的小血管血管炎。
Rheumatol Int. 2021 Sep;41(9):1691-1697. doi: 10.1007/s00296-020-04697-z. Epub 2020 Sep 5.
10
Capacity to Elicit Cytotoxic CD8 T Cell Activity Against subsp. Is Retained in a Vaccine Candidate 35 kDa Peptide Modified for Expression in Mammalian Cells.在哺乳动物细胞中表达的经修饰的 35kDa 肽疫苗候选物保留了针对 subsp. 的细胞毒性 CD8 T 细胞活性的诱导能力。
Front Immunol. 2019 Dec 11;10:2859. doi: 10.3389/fimmu.2019.02859. eCollection 2019.